Patadine QD Eye Drops (Olopatadine Hydrochloride) (Single-use), Patadine QD Eye Drops (Olopatadine Hydrochloride)
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Unimed Pharmaceutical Co., Ltd.
MFDS item code 201900293 · Approved 2019.01.22 · Insurance code 649507831,649508541
Relief of allergic conjunctivitis symptoms
Used to treat symptoms such as swelling, itching, and redness of the eyes caused by allergic conjunctivitis.
Instill 1 drop once daily.
This medication should not be used by patients who have an allergic reaction to the active ingredient or any component. Symptoms like headaches, taste disturbances, dizziness may occur while using this medication. Be cautious as symptoms like punctate keratitis, keratitis, pain, dryness, swelling, itching, discharge, redness, and discomfort may arise. Additionally, symptoms such as glare, blurred vision, and eyelid erythema have been reported rarely. Nasal dryness, rhinitis, dry mouth, contact dermatitis, and fatigue may also occur. This medication may cause cold or pharyngitis-like symptoms in about 10% of patients; weakness, low back pain, flu-like symptoms, frequent coughing, infections, nausea, and sinusitis have also been reported. As this medication contains phosphates, there is an extremely rare chance of corneal calcification occurring in patients with severe corneal damage. Contact lens wearers should refrain from wearing lenses for at least 15 minutes after using this medication. The benzalkonium chloride in this product can irritate the eyes or discolor lenses. This medication is a non-sedating antihistamine, but it may temporarily cause blurred vision after instillation; therefore, one should wait until vision clears before driving or operating machinery. During pregnancy, the risk to the fetus should be carefully considered when using this medication, and in breastfeeding cases, consultation with a physician is necessary to avoid affecting the baby. It can be safely used in children aged three years and older, and the elderly can use it without special precautions. This medication is for ocular use only and should not be taken orally or administered via intravenous injection. Care should be taken to avoid the tip of the container contacting the eye or hands, and the cap should be tightly closed when not in use. If used with other eye drops, a minimum interval of 5 minutes should be maintained, and single-use products should be used only once after opening. In the case of overdose, immediate medical observation and treatment are required.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a well-sealed container to prevent exposure to air or moisture. Additionally, it is important to keep it at a cool temperature between 2 degrees and 25 degrees Celsius to maintain the medication's effectiveness.
(Single-use) A colorless to pale yellow liquid contained in a colorless transparent plastic vial (Multi-use) A colorless to pale yellow liquid contained in an opaque white plastic bottle
(Single-use) (0.35mL/tube) × 30, (0.4mL/tube) × 30 (Multi-use) 3mL/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Unimed Pharmaceutical Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.